Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

We have 268 Cancer Biology PhD Projects, Programmes & Scholarships

Discipline

Discipline

Biological Sciences

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


Cancer Biology PhD Projects, Programmes & Scholarships

We have 268 Cancer Biology PhD Projects, Programmes & Scholarships

A PhD in Cancer Biology would provide you with the opportunity to research a specific cancer in great detail. Whether you’re developing a new treatment, understanding the factors that allow a tumour to arise or innovating better diagnostic tests, you’ll be improving our understanding of cancer and saving lives.

What’s it like to do a PhD in Cancer Biology?

Doing a PhD in Cancer Biology, you’ll develop excellent laboratory skills, particularly in cell culture, working with RNA and studying the proteome. Most Cancer Biology projects link to other subjects and as such, you’ll have experience working with techniques from Cell Biology, Immunology and Genetics.

Some typical research topics in Cancer Biology include:

  • Developing novel diagnostic tests
  • Understanding a potential trigger of metastasis
  • Developing novel therapeutics to treat a specific cancer
  • The immune system and cancer interactions
  • Characterising the role of a specific tumour suppressor or oncogene in a certain cancer

Generally, Cancer Biology programmes are advertised on the university website with the research proposal, including the scope and primary aim of the research pre-determined by the supervisor. These projects are usually fully-funded.

It’s uncommon to propose your own research in Cancer Biology since the additional bench fees make self-funding difficult. It can also be tricky to find a supervisor with the interests that line up well with your suggested project that also have the equipment and expertise to supervise you through your PhD.

In your daily life you’ll be in the laboratory conducting experiments, reading the literature for new methods you could try, analysing old data, and talking to colleagues and your supervisor about your work. In the final year of your PhD you’ll submit a thesis of around 60,000 words that will contribute to the knowledge of your field and you’ll defend your work during your viva exam.

Entry requirements

The entry requirements for most Cancer Biology PhD programmes involve a Masters in a subject directly related to Biology, with at least a Merit or Distinction. If English isn’t your first language, you’ll also need to show that you have the right level of language proficiency.

PhD in Cancer Biology funding options

The Research Council responsible for funding Cancer Biology PhDs in the UK is the Biotechnology and Biological Sciences Research Council (BBSRC). They provide fully-funded studentships including a stipend for living costs, a consumables budget for bench fees and a tuition fee waiver. Students don’t apply directly to the BBSRC, you apply for advertised projects with this funding attached.

It’s uncommon for Cancer Biology PhD students to be ‘self-funded’ due to the additional bench fees. However, if you were planning to fund yourself it might be achievable (depending on your project) through the UK government’s PhD loan and part-time work.

read more

Combining CRISPR-screens and AI to Identify Novel Therapeutic Strategies to Target Cancer-Stroma Interactions

A fully funded PhD Studentship is available to work with Dr Angus Cameron, Reader in Cell Signalling and Tumour Cell Biology, Barts Cancer Institute at Queen Mary University London, Dr Otto Morris, Senior Biological Data Scientist at Exscientia, and Professor Pedro Cutillas, Professor of Cell Signalling and Proteomics, QMUL, Barts Cancer Institute at Queen Mary University London. Read more

AI-based Identification of New Drug Targets for Personalised Oncology

A fully funded PhD Studentship is available to work with Professor Francesca Ciccarelli, Lead of the Centre for Cancer Genomics and Computational Biology, Bart's Cancer Institute at Queen Mary University of London. Read more

Revealing Reactivity in Cancer-Associated Heme Proteins: Novel Time-Resolved Structural Approaches

Indoleamine 2,3-dioxygenase 1 (IDO1) is a heme-containing enzyme involved in the degradation of tryptophan to kynurenine. Cancer cells upregulate IDO1 to escape normal immune responses and, in many cases, a high expression of IDO1 is connected to poor prognosis. Read more

Obtaining insights into how a signalling hub protein Ras activates multiple effectors

The RAS family of small GTPases act as signalling hubs regulating cell proliferation and differentiation. They are highly conserved from yeast to humans, highlighting their fundamental biological roles. Read more

Structural-guided PROTAC targeting of BMX to modulate apoptotic sensitivity in disease

What determines at the molecular level whether a cell lives or dies? Regulation of the cellular life–death switch is essential in healthy cells for normal foetal development and for the clearance of damaged cells. Read more

Molecular characterization of Sam68-driven cytoskeletal reorganization

The cytoskeleton is a complex network of various fibres (microtubules, actin, …) that is essential for cells to maintain their shape and internal organization and for their migration. Read more

(MRC DTP CASE) Multiomic evaluation of differential drug response in metastatic breast cancers

Breast cancers are the most common cancers in women. Estrogen Receptor (ER) plays a major role in breast cancer growth. To stop the cancer from growing further, clinically successful ER-targeting therapies like Fulvestrant, etc were developed. Read more

(MRC DTP CASE) Understanding how tumour associated macrophages control the tumour immune landscape in NF2-Schwannomatosis

Type 2 Neurofibromatosis (NF2), now referred to as NF2-Schwannomatosis (or NF2-SWN), is a rare autosomal dominant tumour pre-disposition syndrome characterised by growth of typically benign tumours throughout the nervous system. Read more

Filtering Results